

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.05260059 |
| 2 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.75614111 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 5.68151540 |
| 4 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.68151540 |
| 5 | protein neddylation (GO:0045116) | 4.97194679 |
| 6 | respiratory electron transport chain (GO:0022904) | 4.83029112 |
| 7 | chaperone-mediated protein transport (GO:0072321) | 4.80256644 |
| 8 | neuron cell-cell adhesion (GO:0007158) | 4.79047304 |
| 9 | electron transport chain (GO:0022900) | 4.70646305 |
| 10 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.53264138 |
| 11 | presynaptic membrane assembly (GO:0097105) | 4.38969358 |
| 12 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.35352784 |
| 13 | presynaptic membrane organization (GO:0097090) | 4.26120543 |
| 14 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.24824354 |
| 15 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.19506545 |
| 16 | axon ensheathment in central nervous system (GO:0032291) | 4.19353695 |
| 17 | central nervous system myelination (GO:0022010) | 4.19353695 |
| 18 | respiratory chain complex IV assembly (GO:0008535) | 4.18125270 |
| 19 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.16201811 |
| 20 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.08643976 |
| 21 | negative regulation of ligase activity (GO:0051352) | 4.08643976 |
| 22 | protein complex biogenesis (GO:0070271) | 4.06067286 |
| 23 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 4.05205355 |
| 24 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 4.05205355 |
| 25 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 4.05205355 |
| 26 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 4.03589946 |
| 27 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 4.03589946 |
| 28 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.99708628 |
| 29 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.99708628 |
| 30 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.89701185 |
| 31 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.89569376 |
| 32 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.88886506 |
| 33 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.88886506 |
| 34 | NADH dehydrogenase complex assembly (GO:0010257) | 3.88886506 |
| 35 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.83951975 |
| 36 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.83951975 |
| 37 | oxidative phosphorylation (GO:0006119) | 3.82016336 |
| 38 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.81372599 |
| 39 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.79640910 |
| 40 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.78398625 |
| 41 | synaptic vesicle exocytosis (GO:0016079) | 3.77576929 |
| 42 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.74199281 |
| 43 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.71005483 |
| 44 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.69525975 |
| 45 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.69525975 |
| 46 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.61874160 |
| 47 | positive regulation of ligase activity (GO:0051351) | 3.56623243 |
| 48 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.54033038 |
| 49 | transferrin transport (GO:0033572) | 3.53584910 |
| 50 | neuronal action potential propagation (GO:0019227) | 3.52289569 |
| 51 | negative regulation of neurotransmitter transport (GO:0051589) | 3.50959573 |
| 52 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.49049545 |
| 53 | hydrogen ion transmembrane transport (GO:1902600) | 3.46981905 |
| 54 | protein localization to synapse (GO:0035418) | 3.45995904 |
| 55 | vocalization behavior (GO:0071625) | 3.43980110 |
| 56 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.41523881 |
| 57 | ribosomal large subunit biogenesis (GO:0042273) | 3.40054476 |
| 58 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.39959489 |
| 59 | termination of RNA polymerase III transcription (GO:0006386) | 3.39959489 |
| 60 | DNA deamination (GO:0045006) | 3.38670563 |
| 61 | regulation of glutamate secretion (GO:0014048) | 3.38040650 |
| 62 | rRNA modification (GO:0000154) | 3.37843531 |
| 63 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.36517322 |
| 64 | platelet dense granule organization (GO:0060155) | 3.32070605 |
| 65 | regulation of mitochondrial translation (GO:0070129) | 3.30402669 |
| 66 | regulation of dopamine metabolic process (GO:0042053) | 3.30061275 |
| 67 | regulation of catecholamine metabolic process (GO:0042069) | 3.30061275 |
| 68 | ferric iron transport (GO:0015682) | 3.26114545 |
| 69 | trivalent inorganic cation transport (GO:0072512) | 3.26114545 |
| 70 | dopamine transport (GO:0015872) | 3.25195351 |
| 71 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.25048077 |
| 72 | positive regulation of synapse assembly (GO:0051965) | 3.24812751 |
| 73 | cotranslational protein targeting to membrane (GO:0006613) | 3.24162492 |
| 74 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.21948612 |
| 75 | cullin deneddylation (GO:0010388) | 3.20900546 |
| 76 | protein targeting to ER (GO:0045047) | 3.19594588 |
| 77 | proton transport (GO:0015992) | 3.16814928 |
| 78 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.15547330 |
| 79 | phagosome maturation (GO:0090382) | 3.14332216 |
| 80 | translation (GO:0006412) | 3.13542889 |
| 81 | substantia nigra development (GO:0021762) | 3.13125731 |
| 82 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.12824435 |
| 83 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.12672984 |
| 84 | protein localization to endoplasmic reticulum (GO:0070972) | 3.12049402 |
| 85 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.11504572 |
| 86 | positive regulation of protein homodimerization activity (GO:0090073) | 3.10624276 |
| 87 | fatty acid elongation (GO:0030497) | 3.09858400 |
| 88 | hydrogen transport (GO:0006818) | 3.09796592 |
| 89 | startle response (GO:0001964) | 3.09340857 |
| 90 | regulation of cellular amine metabolic process (GO:0033238) | 3.08463345 |
| 91 | regulation of ligase activity (GO:0051340) | 3.05907207 |
| 92 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.05729936 |
| 93 | positive regulation of cell cycle arrest (GO:0071158) | 3.04321428 |
| 94 | postsynaptic membrane organization (GO:0001941) | 3.03402608 |
| 95 | neuron-neuron synaptic transmission (GO:0007270) | 3.03313844 |
| 96 | dopamine biosynthetic process (GO:0042416) | 3.02754804 |
| 97 | glutamate receptor signaling pathway (GO:0007215) | 3.01856519 |
| 98 | sequestering of actin monomers (GO:0042989) | 3.00526962 |
| 99 | mitochondrial transport (GO:0006839) | 3.00467642 |
| 100 | neurotransmitter uptake (GO:0001504) | 2.99026852 |
| 101 | aerobic respiration (GO:0009060) | 2.99026505 |
| 102 | CENP-A containing nucleosome assembly (GO:0034080) | 2.98857224 |
| 103 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.97936774 |
| 104 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.97196441 |
| 105 | neuron recognition (GO:0008038) | 2.96512722 |
| 106 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.96095430 |
| 107 | ribosomal small subunit assembly (GO:0000028) | 2.95179666 |
| 108 | negative regulation of protein ubiquitination (GO:0031397) | 2.90039528 |
| 109 | protein K11-linked ubiquitination (GO:0070979) | 2.89570587 |
| 110 | signal peptide processing (GO:0006465) | 2.88912373 |
| 111 | aldehyde catabolic process (GO:0046185) | 2.87174373 |
| 112 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.86093087 |
| 113 | protein deneddylation (GO:0000338) | 2.85439453 |
| 114 | protein K6-linked ubiquitination (GO:0085020) | 2.84897464 |
| 115 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.83752647 |
| 116 | synaptic transmission, dopaminergic (GO:0001963) | 2.83092556 |
| 117 | intracellular protein transmembrane import (GO:0044743) | 2.82708998 |
| 118 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.82486678 |
| 119 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.82486678 |
| 120 | organelle disassembly (GO:1903008) | 2.81990400 |
| 121 | viral transcription (GO:0019083) | 2.81553693 |
| 122 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.81116420 |
| 123 | translational termination (GO:0006415) | 2.80514655 |
| 124 | chromatin remodeling at centromere (GO:0031055) | 2.80471467 |
| 125 | ATP biosynthetic process (GO:0006754) | 2.79409168 |
| 126 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.79379854 |
| 127 | GTP biosynthetic process (GO:0006183) | 2.79277257 |
| 128 | GPI anchor biosynthetic process (GO:0006506) | 2.77331229 |
| 129 | rRNA methylation (GO:0031167) | 2.76897929 |
| 130 | transmission of nerve impulse (GO:0019226) | 2.75832787 |
| 131 | inner mitochondrial membrane organization (GO:0007007) | 2.75217315 |
| 132 | protein localization to cilium (GO:0061512) | 2.75185483 |
| 133 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.74587325 |
| 134 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.73938502 |
| 135 | synaptic transmission, glutamatergic (GO:0035249) | 2.73919720 |
| 136 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.72928530 |
| 137 | proteasome assembly (GO:0043248) | 2.72501333 |
| 138 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.72440234 |
| 139 | positive regulation of mitochondrial fission (GO:0090141) | 2.71681352 |
| 140 | glutamate secretion (GO:0014047) | 2.71183648 |
| 141 | long-term synaptic potentiation (GO:0060291) | 2.68233227 |
| 142 | response to histamine (GO:0034776) | 2.68083457 |
| 143 | behavioral response to cocaine (GO:0048148) | 2.66778797 |
| 144 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.66180679 |
| 145 | serotonin receptor signaling pathway (GO:0007210) | 2.66135541 |
| 146 | protein targeting to mitochondrion (GO:0006626) | 2.60496180 |
| 147 | establishment of protein localization to mitochondrion (GO:0072655) | 2.58972714 |
| 148 | regulation of protein kinase A signaling (GO:0010738) | 2.57575272 |
| 149 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.57404889 |
| 150 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.56816413 |
| 151 | response to cocaine (GO:0042220) | 2.56000640 |
| 152 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.55620388 |
| 153 | positive regulation of response to oxidative stress (GO:1902884) | 2.55620388 |
| 154 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.51570036 |
| 155 | negative regulation of amino acid transport (GO:0051956) | 2.51200036 |
| 156 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.51046986 |
| 157 | regulation of synapse assembly (GO:0051963) | 2.50788559 |
| 158 | protein-cofactor linkage (GO:0018065) | 2.50432219 |
| 159 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.47852991 |
| 160 | regulation of vesicle fusion (GO:0031338) | 2.47087952 |
| 161 | regulation of amino acid transport (GO:0051955) | 2.46369312 |
| 162 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.45907229 |
| 163 | dendrite development (GO:0016358) | 2.45669873 |
| 164 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.45072594 |
| 165 | regulation of synaptic vesicle transport (GO:1902803) | 2.44990032 |
| 166 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.43321987 |
| 167 | protein localization to mitochondrion (GO:0070585) | 2.42406589 |
| 168 | cytochrome complex assembly (GO:0017004) | 2.41572663 |
| 169 | opioid receptor signaling pathway (GO:0038003) | 2.41016686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.17505286 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.10754816 |
| 3 | ELK1_19687146_ChIP-ChIP_HELA_Human | 3.15101424 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.03231550 |
| 5 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.02774841 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.99571988 |
| 7 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.85909126 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.82232523 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.68365216 |
| 10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.65764746 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.51972864 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.49450367 |
| 13 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.46700942 |
| 14 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.46667415 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 2.34200355 |
| 16 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.33281459 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.31272552 |
| 18 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.30802268 |
| 19 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 2.29092878 |
| 20 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.28446550 |
| 21 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.26508582 |
| 22 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.22324567 |
| 23 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.18004336 |
| 24 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.14227343 |
| 25 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.14074871 |
| 26 | FUS_26573619_Chip-Seq_HEK293_Human | 2.12408256 |
| 27 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.11654854 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.11420390 |
| 29 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.11368477 |
| 30 | P300_19829295_ChIP-Seq_ESCs_Human | 2.03514253 |
| 31 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.00288583 |
| 32 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96217016 |
| 33 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.96030357 |
| 34 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.94420077 |
| 35 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.92073458 |
| 36 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.91910882 |
| 37 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.91590050 |
| 38 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.84118892 |
| 39 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.81705651 |
| 40 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.81230095 |
| 41 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.80652678 |
| 42 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.79615692 |
| 43 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.78963990 |
| 44 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.77579113 |
| 45 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.76745317 |
| 46 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.76109526 |
| 47 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.72613599 |
| 48 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.69422156 |
| 49 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.69422156 |
| 50 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.67970232 |
| 51 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.66763806 |
| 52 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.66079240 |
| 53 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.65253430 |
| 54 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.65197699 |
| 55 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.64606478 |
| 56 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.59657623 |
| 57 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.59215742 |
| 58 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.58449979 |
| 59 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.55690939 |
| 60 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.54226081 |
| 61 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.50360584 |
| 62 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.49264773 |
| 63 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.49087715 |
| 64 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.46590072 |
| 65 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.44522716 |
| 66 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.44441003 |
| 67 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.43289987 |
| 68 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.43175296 |
| 69 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.43112375 |
| 70 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.43049769 |
| 71 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.42498137 |
| 72 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.41878384 |
| 73 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.40526240 |
| 74 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39767695 |
| 75 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.38722665 |
| 76 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.38238611 |
| 77 | EWS_26573619_Chip-Seq_HEK293_Human | 1.37998755 |
| 78 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.37938309 |
| 79 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.37695456 |
| 80 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.37436442 |
| 81 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.37217185 |
| 82 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.36717507 |
| 83 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.35508521 |
| 84 | JUN_21703547_ChIP-Seq_K562_Human | 1.34913941 |
| 85 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33527473 |
| 86 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.32370231 |
| 87 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.31638644 |
| 88 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.30762525 |
| 89 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.30530082 |
| 90 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.28413537 |
| 91 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.27144098 |
| 92 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.26572616 |
| 93 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.26315316 |
| 94 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.25988507 |
| 95 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.24815682 |
| 96 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.24720987 |
| 97 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.23456580 |
| 98 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22373449 |
| 99 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.20336685 |
| 100 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.18927060 |
| 101 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.18580193 |
| 102 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.18509836 |
| 103 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.17371209 |
| 104 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.16855651 |
| 105 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.16645700 |
| 106 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.16604466 |
| 107 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.16191129 |
| 108 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.15816875 |
| 109 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.15754322 |
| 110 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.14640447 |
| 111 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.14590535 |
| 112 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.14082201 |
| 113 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.13094918 |
| 114 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.12767447 |
| 115 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.12513354 |
| 116 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.12036909 |
| 117 | AR_20517297_ChIP-Seq_VCAP_Human | 1.10899564 |
| 118 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.10886815 |
| 119 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.09732624 |
| 120 | AR_25329375_ChIP-Seq_VCAP_Human | 1.09628652 |
| 121 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.08826799 |
| 122 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.08826799 |
| 123 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.08358627 |
| 124 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.08019006 |
| 125 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.07889528 |
| 126 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.07591187 |
| 127 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.07559760 |
| 128 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.07439860 |
| 129 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.06958987 |
| 130 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.06707196 |
| 131 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.05823476 |
| 132 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.05353570 |
| 133 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.05120958 |
| 134 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.03978125 |
| 135 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.03330243 |
| 136 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.02560176 |
| 137 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.02451814 |
| 138 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.02074383 |
| 139 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.01902904 |
| 140 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01436974 |
| 141 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.00858942 |
| 142 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00523427 |
| 143 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.00364872 |
| 144 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.99905527 |
| 145 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.98902995 |
| 146 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.98443386 |
| 147 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.97606675 |
| 148 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.97606675 |
| 149 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97135346 |
| 150 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.96907782 |
| 151 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.96482800 |
| 152 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.96094439 |
| 153 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.93925122 |
| 154 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93678507 |
| 155 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.93254970 |
| 156 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.93242333 |
| 157 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.91853064 |
| 158 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.86210589 |
| 159 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.85362787 |
| 160 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.84597303 |
| 161 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.83241095 |
| 162 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.82232101 |
| 163 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.81357028 |
| 164 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.81174565 |
| 165 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.80409275 |
| 166 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.79391394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.76955378 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 5.14036412 |
| 3 | MP0001529_abnormal_vocalization | 3.27714870 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.22133242 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.01532097 |
| 6 | MP0009745_abnormal_behavioral_response | 2.93616034 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 2.92200368 |
| 8 | MP0002736_abnormal_nociception_after | 2.91593544 |
| 9 | MP0003186_abnormal_redox_activity | 2.89886516 |
| 10 | MP0002064_seizures | 2.84491242 |
| 11 | MP0001905_abnormal_dopamine_level | 2.82330039 |
| 12 | MP0008058_abnormal_DNA_repair | 2.81788542 |
| 13 | MP0006276_abnormal_autonomic_nervous | 2.76907966 |
| 14 | MP0004270_analgesia | 2.69460594 |
| 15 | MP0009046_muscle_twitch | 2.68785075 |
| 16 | MP0002272_abnormal_nervous_system | 2.64111711 |
| 17 | MP0002063_abnormal_learning/memory/cond | 2.46922102 |
| 18 | MP0002572_abnormal_emotion/affect_behav | 2.46684205 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.39630512 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 2.31439192 |
| 21 | MP0001440_abnormal_grooming_behavior | 2.27406434 |
| 22 | MP0005423_abnormal_somatic_nervous | 2.27036307 |
| 23 | MP0001188_hyperpigmentation | 2.24522084 |
| 24 | MP0001486_abnormal_startle_reflex | 2.24518290 |
| 25 | MP0009697_abnormal_copulation | 2.17550612 |
| 26 | MP0001835_abnormal_antigen_presentation | 2.16481069 |
| 27 | MP0003786_premature_aging | 2.12215382 |
| 28 | MP0003195_calcinosis | 2.08273017 |
| 29 | MP0004142_abnormal_muscle_tone | 2.08139019 |
| 30 | MP0009379_abnormal_foot_pigmentation | 2.05635217 |
| 31 | MP0005671_abnormal_response_to | 2.02154289 |
| 32 | MP0008877_abnormal_DNA_methylation | 2.00942875 |
| 33 | MP0002067_abnormal_sensory_capabilities | 1.91961760 |
| 34 | MP0001501_abnormal_sleep_pattern | 1.91502713 |
| 35 | MP0001970_abnormal_pain_threshold | 1.91451137 |
| 36 | MP0005171_absent_coat_pigmentation | 1.90719071 |
| 37 | MP0000778_abnormal_nervous_system | 1.87396341 |
| 38 | MP0005075_abnormal_melanosome_morpholog | 1.84115103 |
| 39 | MP0002733_abnormal_thermal_nociception | 1.82463475 |
| 40 | MP0003136_yellow_coat_color | 1.75272675 |
| 41 | MP0003718_maternal_effect | 1.74569866 |
| 42 | MP0000920_abnormal_myelination | 1.70775557 |
| 43 | MP0001984_abnormal_olfaction | 1.68308736 |
| 44 | MP0010094_abnormal_chromosome_stability | 1.67999774 |
| 45 | MP0004742_abnormal_vestibular_system | 1.67124785 |
| 46 | MP0009785_altered_susceptibility_to | 1.66171702 |
| 47 | MP0004924_abnormal_behavior | 1.65633844 |
| 48 | MP0005386_behavior/neurological_phenoty | 1.65633844 |
| 49 | MP0002822_catalepsy | 1.64590780 |
| 50 | MP0001764_abnormal_homeostasis | 1.64201208 |
| 51 | MP0005646_abnormal_pituitary_gland | 1.61324494 |
| 52 | MP0008875_abnormal_xenobiotic_pharmacok | 1.61003906 |
| 53 | MP0002148_abnormal_hypersensitivity_rea | 1.57342921 |
| 54 | MP0002277_abnormal_respiratory_mucosa | 1.56719162 |
| 55 | MP0002184_abnormal_innervation | 1.54583806 |
| 56 | MP0002938_white_spotting | 1.53173760 |
| 57 | MP0008007_abnormal_cellular_replicative | 1.49756197 |
| 58 | MP0005409_darkened_coat_color | 1.49196185 |
| 59 | MP0005408_hypopigmentation | 1.49160310 |
| 60 | MP0010386_abnormal_urinary_bladder | 1.43625035 |
| 61 | MP0005645_abnormal_hypothalamus_physiol | 1.42302946 |
| 62 | MP0003122_maternal_imprinting | 1.42112958 |
| 63 | MP0002557_abnormal_social/conspecific_i | 1.40583191 |
| 64 | MP0002876_abnormal_thyroid_physiology | 1.40058802 |
| 65 | MP0004957_abnormal_blastocyst_morpholog | 1.39321936 |
| 66 | MP0005551_abnormal_eye_electrophysiolog | 1.39311147 |
| 67 | MP0008995_early_reproductive_senescence | 1.36346887 |
| 68 | MP0003011_delayed_dark_adaptation | 1.35766262 |
| 69 | MP0003724_increased_susceptibility_to | 1.32237953 |
| 70 | MP0001986_abnormal_taste_sensitivity | 1.31278932 |
| 71 | MP0003329_amyloid_beta_deposits | 1.31251707 |
| 72 | MP0002638_abnormal_pupillary_reflex | 1.30133302 |
| 73 | MP0004215_abnormal_myocardial_fiber | 1.25585318 |
| 74 | MP0002066_abnormal_motor_capabilities/c | 1.24151820 |
| 75 | MP0002882_abnormal_neuron_morphology | 1.24116308 |
| 76 | MP0002837_dystrophic_cardiac_calcinosis | 1.23060410 |
| 77 | MP0005332_abnormal_amino_acid | 1.22719285 |
| 78 | MP0009764_decreased_sensitivity_to | 1.22274984 |
| 79 | MP0000372_irregular_coat_pigmentation | 1.20464278 |
| 80 | MP0001502_abnormal_circadian_rhythm | 1.17138092 |
| 81 | MP0002163_abnormal_gland_morphology | 1.17134987 |
| 82 | MP0001963_abnormal_hearing_physiology | 1.15347858 |
| 83 | MP0005636_abnormal_mineral_homeostasis | 1.15204415 |
| 84 | MP0002229_neurodegeneration | 1.14559524 |
| 85 | MP0005379_endocrine/exocrine_gland_phen | 1.13292181 |
| 86 | MP0001485_abnormal_pinna_reflex | 1.11432870 |
| 87 | MP0003693_abnormal_embryo_hatching | 1.09964822 |
| 88 | MP0000955_abnormal_spinal_cord | 1.07650374 |
| 89 | MP0002095_abnormal_skin_pigmentation | 1.07338501 |
| 90 | MP0000358_abnormal_cell_content/ | 1.03070723 |
| 91 | MP0008569_lethality_at_weaning | 1.02049850 |
| 92 | MP0003634_abnormal_glial_cell | 1.01810918 |
| 93 | MP0001853_heart_inflammation | 1.00481895 |
| 94 | MP0006292_abnormal_olfactory_placode | 0.99778754 |
| 95 | MP0002752_abnormal_somatic_nervous | 0.99711462 |
| 96 | MP0004811_abnormal_neuron_physiology | 0.98396329 |
| 97 | MP0005266_abnormal_metabolism | 0.97526156 |
| 98 | MP0005367_renal/urinary_system_phenotyp | 0.96229299 |
| 99 | MP0000516_abnormal_urinary_system | 0.96229299 |
| 100 | MP0002139_abnormal_hepatobiliary_system | 0.96019606 |
| 101 | MP0000026_abnormal_inner_ear | 0.94676623 |
| 102 | MP0002234_abnormal_pharynx_morphology | 0.94314906 |
| 103 | MP0003879_abnormal_hair_cell | 0.91915721 |
| 104 | MP0003631_nervous_system_phenotype | 0.91675387 |
| 105 | MP0004043_abnormal_pH_regulation | 0.91282460 |
| 106 | MP0003077_abnormal_cell_cycle | 0.90866741 |
| 107 | MP0000631_abnormal_neuroendocrine_gland | 0.89618615 |
| 108 | MP0002166_altered_tumor_susceptibility | 0.88299738 |
| 109 | MP0006035_abnormal_mitochondrial_morpho | 0.87980054 |
| 110 | MP0003633_abnormal_nervous_system | 0.87778971 |
| 111 | MP0002006_tumorigenesis | 0.87120601 |
| 112 | MP0008873_increased_physiological_sensi | 0.86788279 |
| 113 | MP0005085_abnormal_gallbladder_physiolo | 0.86730228 |
| 114 | MP0001800_abnormal_humoral_immune | 0.84557925 |
| 115 | MP0008932_abnormal_embryonic_tissue | 0.84361143 |
| 116 | MP0002090_abnormal_vision | 0.83877426 |
| 117 | MP0003787_abnormal_imprinting | 0.83421591 |
| 118 | MP0002102_abnormal_ear_morphology | 0.83378066 |
| 119 | MP0001929_abnormal_gametogenesis | 0.82607438 |
| 120 | MP0000343_altered_response_to | 0.82380452 |
| 121 | MP0005253_abnormal_eye_physiology | 0.81954784 |
| 122 | MP0002452_abnormal_antigen_presenting | 0.81888721 |
| 123 | MP0006082_CNS_inflammation | 0.81568331 |
| 124 | MP0005389_reproductive_system_phenotype | 0.81293622 |
| 125 | MP0003252_abnormal_bile_duct | 0.81144828 |
| 126 | MP0006072_abnormal_retinal_apoptosis | 0.79137913 |
| 127 | MP0002152_abnormal_brain_morphology | 0.78217496 |
| 128 | MP0002210_abnormal_sex_determination | 0.77543313 |
| 129 | MP0003137_abnormal_impulse_conducting | 0.76493039 |
| 130 | MP0003632_abnormal_nervous_system | 0.76187849 |
| 131 | MP0000015_abnormal_ear_pigmentation | 0.76160710 |
| 132 | MP0008260_abnormal_autophagy | 0.76084085 |
| 133 | MP0005499_abnormal_olfactory_system | 0.76065096 |
| 134 | MP0005394_taste/olfaction_phenotype | 0.76065096 |
| 135 | MP0001919_abnormal_reproductive_system | 0.75918982 |
| 136 | MP0005410_abnormal_fertilization | 0.74563218 |
| 137 | MP0001664_abnormal_digestion | 0.74083195 |
| 138 | MP0001756_abnormal_urination | 0.73874968 |
| 139 | MP0008872_abnormal_physiological_respon | 0.72606020 |
| 140 | MP0002751_abnormal_autonomic_nervous | 0.72329559 |
| 141 | MP0005376_homeostasis/metabolism_phenot | 0.72050400 |
| 142 | MP0002723_abnormal_immune_serum | 0.71929918 |
| 143 | MP0001845_abnormal_inflammatory_respons | 0.71592618 |
| 144 | MP0006054_spinal_hemorrhage | 0.71453146 |
| 145 | MP0005000_abnormal_immune_tolerance | 0.70988759 |
| 146 | MP0003690_abnormal_glial_cell | 0.70761303 |
| 147 | MP0008469_abnormal_protein_level | 0.69198750 |
| 148 | MP0005084_abnormal_gallbladder_morpholo | 0.68204780 |
| 149 | MP0000653_abnormal_sex_gland | 0.67832010 |
| 150 | MP0001727_abnormal_embryo_implantation | 0.67771737 |
| 151 | MP0000647_abnormal_sebaceous_gland | 0.67371064 |
| 152 | MP0004885_abnormal_endolymph | 0.67013469 |
| 153 | MP0006036_abnormal_mitochondrial_physio | 0.65172176 |
| 154 | MP0005535_abnormal_body_temperature | 0.64061082 |
| 155 | MP0003938_abnormal_ear_development | 0.61797224 |
| 156 | MP0003950_abnormal_plasma_membrane | 0.61553068 |
| 157 | MP0001177_atelectasis | 0.61393639 |
| 158 | MP0002069_abnormal_eating/drinking_beha | 0.61186126 |
| 159 | MP0004145_abnormal_muscle_electrophysio | 0.60568668 |
| 160 | MP0001542_abnormal_bone_strength | 0.59868879 |
| 161 | MP0004147_increased_porphyrin_level | 0.58744502 |
| 162 | MP0008789_abnormal_olfactory_epithelium | 0.58744387 |
| 163 | MP0000604_amyloidosis | 0.57494584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.94559423 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.29261639 |
| 3 | Progressive macrocephaly (HP:0004481) | 5.09035764 |
| 4 | Mitochondrial inheritance (HP:0001427) | 5.05994703 |
| 5 | Focal motor seizures (HP:0011153) | 4.99792326 |
| 6 | Acute encephalopathy (HP:0006846) | 4.61990897 |
| 7 | Abnormality of glycolysis (HP:0004366) | 4.19141136 |
| 8 | Increased serum pyruvate (HP:0003542) | 4.19141136 |
| 9 | Increased CSF lactate (HP:0002490) | 4.16971010 |
| 10 | Hepatocellular necrosis (HP:0001404) | 4.02161377 |
| 11 | Atonic seizures (HP:0010819) | 3.65877899 |
| 12 | Increased hepatocellular lipid droplets (HP:0006565) | 3.60424125 |
| 13 | Epileptic encephalopathy (HP:0200134) | 3.49686911 |
| 14 | Renal Fanconi syndrome (HP:0001994) | 3.45576926 |
| 15 | Myokymia (HP:0002411) | 3.43283479 |
| 16 | Optic disc pallor (HP:0000543) | 3.35888031 |
| 17 | Leukodystrophy (HP:0002415) | 3.25764777 |
| 18 | Neuroendocrine neoplasm (HP:0100634) | 3.09922270 |
| 19 | Medial flaring of the eyebrow (HP:0010747) | 3.09217104 |
| 20 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.08586645 |
| 21 | Hyperventilation (HP:0002883) | 3.08585347 |
| 22 | Congenital, generalized hypertrichosis (HP:0004540) | 3.05347178 |
| 23 | 3-Methylglutaconic aciduria (HP:0003535) | 3.05107245 |
| 24 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.04898828 |
| 25 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.04623751 |
| 26 | Pheochromocytoma (HP:0002666) | 3.04505377 |
| 27 | Aplastic anemia (HP:0001915) | 3.00554635 |
| 28 | Hepatic necrosis (HP:0002605) | 2.97720171 |
| 29 | Gait imbalance (HP:0002141) | 2.93185785 |
| 30 | Lipid accumulation in hepatocytes (HP:0006561) | 2.92155255 |
| 31 | Exercise intolerance (HP:0003546) | 2.86497082 |
| 32 | Limb dystonia (HP:0002451) | 2.86357464 |
| 33 | Focal seizures (HP:0007359) | 2.86042441 |
| 34 | Absence seizures (HP:0002121) | 2.85859724 |
| 35 | Respiratory failure (HP:0002878) | 2.85114712 |
| 36 | Febrile seizures (HP:0002373) | 2.83681011 |
| 37 | Methylmalonic aciduria (HP:0012120) | 2.82573076 |
| 38 | Parakeratosis (HP:0001036) | 2.81718277 |
| 39 | Abnormal hair whorl (HP:0010721) | 2.77477141 |
| 40 | Congenital primary aphakia (HP:0007707) | 2.75610784 |
| 41 | Cerebral edema (HP:0002181) | 2.70645199 |
| 42 | Nephrogenic diabetes insipidus (HP:0009806) | 2.67529198 |
| 43 | Dialeptic seizures (HP:0011146) | 2.66418635 |
| 44 | Lethargy (HP:0001254) | 2.65700244 |
| 45 | Type I transferrin isoform profile (HP:0003642) | 2.64096864 |
| 46 | Neurofibrillary tangles (HP:0002185) | 2.63008299 |
| 47 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.61979878 |
| 48 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.61979878 |
| 49 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.55151533 |
| 50 | Abnormality of alanine metabolism (HP:0010916) | 2.55151533 |
| 51 | Hyperalaninemia (HP:0003348) | 2.55151533 |
| 52 | Lactic acidosis (HP:0003128) | 2.54892803 |
| 53 | Pancreatic cysts (HP:0001737) | 2.53359899 |
| 54 | Hypothermia (HP:0002045) | 2.47932370 |
| 55 | Retinal dysplasia (HP:0007973) | 2.47781478 |
| 56 | Vaginal atresia (HP:0000148) | 2.45574585 |
| 57 | Molar tooth sign on MRI (HP:0002419) | 2.43589810 |
| 58 | Abnormality of midbrain morphology (HP:0002418) | 2.43589810 |
| 59 | X-linked dominant inheritance (HP:0001423) | 2.43007292 |
| 60 | Increased serum lactate (HP:0002151) | 2.41523900 |
| 61 | Genital tract atresia (HP:0001827) | 2.41363853 |
| 62 | Progressive cerebellar ataxia (HP:0002073) | 2.40564484 |
| 63 | Broad-based gait (HP:0002136) | 2.39768738 |
| 64 | Abnormality of renal resorption (HP:0011038) | 2.39224210 |
| 65 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.37568599 |
| 66 | Abnormality of methionine metabolism (HP:0010901) | 2.37342606 |
| 67 | Abnormality of urine glucose concentration (HP:0011016) | 2.36758257 |
| 68 | Glycosuria (HP:0003076) | 2.36758257 |
| 69 | Increased intramyocellular lipid droplets (HP:0012240) | 2.36165565 |
| 70 | Visual hallucinations (HP:0002367) | 2.31638787 |
| 71 | Sensory axonal neuropathy (HP:0003390) | 2.26609407 |
| 72 | Generalized aminoaciduria (HP:0002909) | 2.23399094 |
| 73 | Exertional dyspnea (HP:0002875) | 2.21473830 |
| 74 | Generalized tonic-clonic seizures (HP:0002069) | 2.21018484 |
| 75 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.16581672 |
| 76 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.16581672 |
| 77 | Macrocytic anemia (HP:0001972) | 2.16396632 |
| 78 | Polyphagia (HP:0002591) | 2.15548856 |
| 79 | Abnormal number of erythroid precursors (HP:0012131) | 2.13459299 |
| 80 | Delusions (HP:0000746) | 2.12812850 |
| 81 | Cerebral inclusion bodies (HP:0100314) | 2.12653321 |
| 82 | Abnormal pupillary function (HP:0007686) | 2.12384459 |
| 83 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.12296983 |
| 84 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.12296983 |
| 85 | Abnormal protein glycosylation (HP:0012346) | 2.12296983 |
| 86 | Abnormal glycosylation (HP:0012345) | 2.12296983 |
| 87 | Pancreatic fibrosis (HP:0100732) | 2.10304240 |
| 88 | Abnormality of serum amino acid levels (HP:0003112) | 2.09909687 |
| 89 | Degeneration of anterior horn cells (HP:0002398) | 2.09806280 |
| 90 | Abnormality of the anterior horn cell (HP:0006802) | 2.09806280 |
| 91 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.07816489 |
| 92 | Dicarboxylic aciduria (HP:0003215) | 2.07816489 |
| 93 | Progressive inability to walk (HP:0002505) | 2.07261139 |
| 94 | Renal cortical cysts (HP:0000803) | 2.06765897 |
| 95 | Anxiety (HP:0000739) | 2.05674545 |
| 96 | Amniotic constriction ring (HP:0009775) | 2.04342031 |
| 97 | Abnormality of placental membranes (HP:0011409) | 2.04342031 |
| 98 | True hermaphroditism (HP:0010459) | 2.01725256 |
| 99 | Abnormality of vitamin B metabolism (HP:0004340) | 2.01147480 |
| 100 | Cerebral hypomyelination (HP:0006808) | 1.98546731 |
| 101 | Esotropia (HP:0000565) | 1.97846115 |
| 102 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.96910710 |
| 103 | Poor suck (HP:0002033) | 1.93738292 |
| 104 | Hyperphosphaturia (HP:0003109) | 1.93711668 |
| 105 | Respiratory difficulties (HP:0002880) | 1.91690916 |
| 106 | Oral leukoplakia (HP:0002745) | 1.91210138 |
| 107 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.90667036 |
| 108 | Inability to walk (HP:0002540) | 1.90315890 |
| 109 | Abnormality of the corticospinal tract (HP:0002492) | 1.89844756 |
| 110 | Cerebral hemorrhage (HP:0001342) | 1.89620128 |
| 111 | Pancytopenia (HP:0001876) | 1.89497999 |
| 112 | Autoamputation (HP:0001218) | 1.89135688 |
| 113 | Supranuclear gaze palsy (HP:0000605) | 1.88943887 |
| 114 | Emotional lability (HP:0000712) | 1.88802605 |
| 115 | Amblyopia (HP:0000646) | 1.86834190 |
| 116 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.84302632 |
| 117 | Poor coordination (HP:0002370) | 1.83002437 |
| 118 | Nephronophthisis (HP:0000090) | 1.80795925 |
| 119 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.80537041 |
| 120 | Palpitations (HP:0001962) | 1.79650537 |
| 121 | Reduced antithrombin III activity (HP:0001976) | 1.78632983 |
| 122 | Abnormal ciliary motility (HP:0012262) | 1.78595424 |
| 123 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.74983590 |
| 124 | Abnormal eating behavior (HP:0100738) | 1.74449879 |
| 125 | Abnormality of the renal cortex (HP:0011035) | 1.74374688 |
| 126 | Hyperglycinemia (HP:0002154) | 1.74281954 |
| 127 | Blindness (HP:0000618) | 1.73262258 |
| 128 | Methylmalonic acidemia (HP:0002912) | 1.73212074 |
| 129 | Scanning speech (HP:0002168) | 1.72516698 |
| 130 | Dysmetria (HP:0001310) | 1.71876051 |
| 131 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.71219791 |
| 132 | Absent/shortened dynein arms (HP:0200106) | 1.71219791 |
| 133 | Constricted visual fields (HP:0001133) | 1.69846191 |
| 134 | Specific learning disability (HP:0001328) | 1.69410614 |
| 135 | Microvesicular hepatic steatosis (HP:0001414) | 1.68978973 |
| 136 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.68781281 |
| 137 | Nausea (HP:0002018) | 1.68419864 |
| 138 | CNS demyelination (HP:0007305) | 1.67923060 |
| 139 | Diplopia (HP:0000651) | 1.66001371 |
| 140 | Abnormality of binocular vision (HP:0011514) | 1.66001371 |
| 141 | Progressive microcephaly (HP:0000253) | 1.65895277 |
| 142 | Metabolic acidosis (HP:0001942) | 1.65393057 |
| 143 | Delayed CNS myelination (HP:0002188) | 1.65109976 |
| 144 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.63203373 |
| 145 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.63203373 |
| 146 | Abolished electroretinogram (ERG) (HP:0000550) | 1.63014634 |
| 147 | Increased muscle lipid content (HP:0009058) | 1.62674156 |
| 148 | Epileptiform EEG discharges (HP:0011182) | 1.61454882 |
| 149 | Gaze-evoked nystagmus (HP:0000640) | 1.60753843 |
| 150 | Abnormal spermatogenesis (HP:0008669) | 1.59569012 |
| 151 | Progressive external ophthalmoplegia (HP:0000590) | 1.58864625 |
| 152 | Hypomagnesemia (HP:0002917) | 1.58335037 |
| 153 | Generalized myoclonic seizures (HP:0002123) | 1.57086808 |
| 154 | Type 2 muscle fiber atrophy (HP:0003554) | 1.56220077 |
| 155 | Pallor (HP:0000980) | 1.54962994 |
| 156 | Megaloblastic anemia (HP:0001889) | 1.54723789 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.37296028 |
| 2 | MAP3K12 | 3.56811244 |
| 3 | VRK2 | 3.36817312 |
| 4 | MAP4K2 | 2.51619520 |
| 5 | MAP2K7 | 2.43469912 |
| 6 | OXSR1 | 2.39635393 |
| 7 | STK39 | 2.35401759 |
| 8 | NTRK3 | 2.30165272 |
| 9 | STK16 | 2.29781526 |
| 10 | TRIM28 | 2.25356929 |
| 11 | PNCK | 2.19853750 |
| 12 | EPHA4 | 2.17591226 |
| 13 | NME1 | 2.16076367 |
| 14 | PLK2 | 2.15817500 |
| 15 | ZAK | 2.07617210 |
| 16 | NUAK1 | 2.01322284 |
| 17 | MARK1 | 2.01109696 |
| 18 | PBK | 1.99644541 |
| 19 | RIPK4 | 1.97910174 |
| 20 | CDK19 | 1.97015184 |
| 21 | BCR | 1.95530417 |
| 22 | ARAF | 1.93712765 |
| 23 | TNIK | 1.92745548 |
| 24 | SRPK1 | 1.89776077 |
| 25 | MST4 | 1.87335008 |
| 26 | MAP3K4 | 1.78886139 |
| 27 | BMPR2 | 1.71541591 |
| 28 | NEK1 | 1.64741663 |
| 29 | BMPR1B | 1.61793028 |
| 30 | MINK1 | 1.61387314 |
| 31 | TXK | 1.53047166 |
| 32 | LIMK1 | 1.52775846 |
| 33 | GRK5 | 1.50383902 |
| 34 | BCKDK | 1.44315563 |
| 35 | MAPKAPK5 | 1.42890353 |
| 36 | FRK | 1.42442976 |
| 37 | GRK7 | 1.40666746 |
| 38 | ACVR1B | 1.32935630 |
| 39 | NME2 | 1.29923365 |
| 40 | PLK4 | 1.28950232 |
| 41 | WNK4 | 1.28861503 |
| 42 | CAMK2B | 1.28073463 |
| 43 | MAPK13 | 1.26150156 |
| 44 | ADRBK2 | 1.24167617 |
| 45 | CAMK2A | 1.15212828 |
| 46 | PDK2 | 1.14188142 |
| 47 | TAOK3 | 1.09850098 |
| 48 | MYLK | 1.08339468 |
| 49 | GRK1 | 1.06012024 |
| 50 | CDC7 | 1.04718657 |
| 51 | PRPF4B | 1.02155092 |
| 52 | MAP2K4 | 1.01893277 |
| 53 | FGR | 1.01290072 |
| 54 | WEE1 | 0.99618356 |
| 55 | NTRK2 | 0.99486954 |
| 56 | WNK3 | 0.98997475 |
| 57 | INSRR | 0.98396238 |
| 58 | BRAF | 0.97916481 |
| 59 | BUB1 | 0.97411603 |
| 60 | CCNB1 | 0.96959843 |
| 61 | EIF2AK2 | 0.96567821 |
| 62 | DYRK2 | 0.93957449 |
| 63 | MUSK | 0.93733535 |
| 64 | KDR | 0.92973166 |
| 65 | TESK1 | 0.91889938 |
| 66 | VRK1 | 0.91824326 |
| 67 | FES | 0.91619812 |
| 68 | UHMK1 | 0.91314092 |
| 69 | PRKCG | 0.90856579 |
| 70 | DAPK1 | 0.90332252 |
| 71 | CAMK2D | 0.89150075 |
| 72 | PRKCE | 0.88284052 |
| 73 | BRSK2 | 0.87491405 |
| 74 | CSNK1G3 | 0.86669160 |
| 75 | SCYL2 | 0.85193564 |
| 76 | TEC | 0.84693896 |
| 77 | CDK14 | 0.83187326 |
| 78 | AKT3 | 0.80886350 |
| 79 | PTK2B | 0.80671920 |
| 80 | PAK4 | 0.80520440 |
| 81 | MAP3K9 | 0.80490043 |
| 82 | CDK5 | 0.80090227 |
| 83 | PKN1 | 0.79940007 |
| 84 | SIK3 | 0.78384166 |
| 85 | ADRBK1 | 0.77563555 |
| 86 | CDK18 | 0.75902490 |
| 87 | TSSK6 | 0.75898911 |
| 88 | NTRK1 | 0.75794699 |
| 89 | NEK6 | 0.75294937 |
| 90 | EIF2AK1 | 0.74460855 |
| 91 | ILK | 0.74451241 |
| 92 | PLK1 | 0.71314232 |
| 93 | CAMKK2 | 0.70728860 |
| 94 | CSNK1G2 | 0.70360903 |
| 95 | CDK15 | 0.69539923 |
| 96 | EIF2AK3 | 0.69091958 |
| 97 | SGK223 | 0.68640830 |
| 98 | SGK494 | 0.68640830 |
| 99 | PINK1 | 0.66661232 |
| 100 | IKBKB | 0.66580777 |
| 101 | ROCK2 | 0.66342064 |
| 102 | CAMK2G | 0.65812453 |
| 103 | TLK1 | 0.65775183 |
| 104 | KIT | 0.62578165 |
| 105 | RPS6KA4 | 0.62550818 |
| 106 | DAPK2 | 0.62439107 |
| 107 | CDK11A | 0.62177768 |
| 108 | TTK | 0.58781304 |
| 109 | DYRK1A | 0.57783110 |
| 110 | YES1 | 0.56001008 |
| 111 | CSNK2A1 | 0.55165378 |
| 112 | RPS6KA5 | 0.52247738 |
| 113 | AURKB | 0.51729931 |
| 114 | TESK2 | 0.51587707 |
| 115 | TAF1 | 0.51007143 |
| 116 | DYRK3 | 0.50363805 |
| 117 | CSNK2A2 | 0.49417463 |
| 118 | ABL2 | 0.48247568 |
| 119 | CDK8 | 0.47299067 |
| 120 | OBSCN | 0.47043829 |
| 121 | DAPK3 | 0.46836342 |
| 122 | PLK3 | 0.46547211 |
| 123 | CSNK1G1 | 0.46008664 |
| 124 | TGFBR1 | 0.45982468 |
| 125 | MKNK1 | 0.45790966 |
| 126 | PHKG2 | 0.44349001 |
| 127 | PHKG1 | 0.44349001 |
| 128 | IRAK2 | 0.43510229 |
| 129 | PRKACA | 0.43294571 |
| 130 | CSNK1A1L | 0.41531949 |
| 131 | STK10 | 0.40837878 |
| 132 | IRAK4 | 0.38773106 |
| 133 | ATR | 0.38598730 |
| 134 | LYN | 0.37706613 |
| 135 | CSF1R | 0.37662741 |
| 136 | STK38L | 0.36564047 |
| 137 | PRKCQ | 0.36433156 |
| 138 | FLT3 | 0.35893651 |
| 139 | WNK1 | 0.35230158 |
| 140 | IKBKE | 0.35064920 |
| 141 | KSR1 | 0.33057920 |
| 142 | PIM2 | 0.32990477 |
| 143 | MAP3K13 | 0.32307048 |
| 144 | CDK3 | 0.31450791 |
| 145 | PRKG1 | 0.30750635 |
| 146 | CSNK1A1 | 0.30355706 |
| 147 | MOS | 0.28242926 |
| 148 | MKNK2 | 0.28029446 |
| 149 | ERBB3 | 0.27855061 |
| 150 | PAK3 | 0.26859944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 5.17385800 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 4.11910669 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.35035130 |
| 4 | Alzheimers disease_Homo sapiens_hsa05010 | 3.34677836 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 3.15662590 |
| 6 | Huntingtons disease_Homo sapiens_hsa05016 | 2.91472224 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 2.88822373 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.71028931 |
| 9 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.25697843 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.24001673 |
| 11 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.22277537 |
| 12 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.21937103 |
| 13 | Mismatch repair_Homo sapiens_hsa03430 | 2.17765226 |
| 14 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.15149825 |
| 15 | Homologous recombination_Homo sapiens_hsa03440 | 2.08950918 |
| 16 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.98637389 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.86223561 |
| 18 | GABAergic synapse_Homo sapiens_hsa04727 | 1.85004423 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.77764488 |
| 20 | Morphine addiction_Homo sapiens_hsa05032 | 1.71910858 |
| 21 | DNA replication_Homo sapiens_hsa03030 | 1.66818039 |
| 22 | Phototransduction_Homo sapiens_hsa04744 | 1.66037872 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.61724293 |
| 24 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.59162250 |
| 25 | RNA polymerase_Homo sapiens_hsa03020 | 1.57352708 |
| 26 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.56283277 |
| 27 | Circadian entrainment_Homo sapiens_hsa04713 | 1.51520873 |
| 28 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.51452770 |
| 29 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.50828133 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.49613984 |
| 31 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.48114265 |
| 32 | Ribosome_Homo sapiens_hsa03010 | 1.47784317 |
| 33 | Taste transduction_Homo sapiens_hsa04742 | 1.47121125 |
| 34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.46026760 |
| 35 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.45018577 |
| 36 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.40659109 |
| 37 | RNA degradation_Homo sapiens_hsa03018 | 1.35211417 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.34697310 |
| 39 | Long-term potentiation_Homo sapiens_hsa04720 | 1.34339934 |
| 40 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.29829082 |
| 41 | Long-term depression_Homo sapiens_hsa04730 | 1.28145191 |
| 42 | Olfactory transduction_Homo sapiens_hsa04740 | 1.27495273 |
| 43 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.26045855 |
| 44 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.26039139 |
| 45 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.22381851 |
| 46 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.21491202 |
| 47 | Spliceosome_Homo sapiens_hsa03040 | 1.21032367 |
| 48 | Base excision repair_Homo sapiens_hsa03410 | 1.19521402 |
| 49 | Phagosome_Homo sapiens_hsa04145 | 1.16751161 |
| 50 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.16531494 |
| 51 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.11570825 |
| 52 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.09661358 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.09495958 |
| 54 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.07662476 |
| 55 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.06177395 |
| 56 | Cocaine addiction_Homo sapiens_hsa05030 | 1.02515080 |
| 57 | Salivary secretion_Homo sapiens_hsa04970 | 0.98165572 |
| 58 | Renin secretion_Homo sapiens_hsa04924 | 0.97284908 |
| 59 | Peroxisome_Homo sapiens_hsa04146 | 0.96127849 |
| 60 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.93227897 |
| 61 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.92322945 |
| 62 | RNA transport_Homo sapiens_hsa03013 | 0.89440157 |
| 63 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.86217483 |
| 64 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.83845525 |
| 65 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79340098 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79299679 |
| 67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.77573233 |
| 68 | Axon guidance_Homo sapiens_hsa04360 | 0.77122148 |
| 69 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.75612024 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.75545230 |
| 71 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.74662828 |
| 72 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.72073374 |
| 73 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.70662728 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70246084 |
| 75 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.69754076 |
| 76 | Insulin secretion_Homo sapiens_hsa04911 | 0.69662616 |
| 77 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.68650702 |
| 78 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.65547335 |
| 79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65218129 |
| 80 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.63667540 |
| 81 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.63374799 |
| 82 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.62816982 |
| 83 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.62494313 |
| 84 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.61552377 |
| 85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60841850 |
| 86 | Gap junction_Homo sapiens_hsa04540 | 0.60305840 |
| 87 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.60082452 |
| 88 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.58997190 |
| 89 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57943935 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57906543 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57630309 |
| 92 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.54324502 |
| 93 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.54217276 |
| 94 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.53201737 |
| 95 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52782147 |
| 96 | Basal transcription factors_Homo sapiens_hsa03022 | 0.52665488 |
| 97 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.52201399 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50934119 |
| 99 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.50395230 |
| 100 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49147823 |
| 101 | Allograft rejection_Homo sapiens_hsa05330 | 0.48912598 |
| 102 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.46968785 |
| 103 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46474045 |
| 104 | Purine metabolism_Homo sapiens_hsa00230 | 0.45200626 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45139123 |
| 106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44874178 |
| 107 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.44454383 |
| 108 | Asthma_Homo sapiens_hsa05310 | 0.44403167 |
| 109 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.43763761 |
| 110 | Alcoholism_Homo sapiens_hsa05034 | 0.42783238 |
| 111 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42567344 |
| 112 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.42051739 |
| 113 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.41795407 |
| 114 | Viral myocarditis_Homo sapiens_hsa05416 | 0.39671156 |
| 115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.39644686 |
| 116 | Carbon metabolism_Homo sapiens_hsa01200 | 0.39078147 |
| 117 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.38479374 |
| 118 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.38432681 |
| 119 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.37391649 |
| 120 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36399564 |
| 121 | Legionellosis_Homo sapiens_hsa05134 | 0.36104788 |
| 122 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.35782284 |
| 123 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.35611665 |
| 124 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.35084383 |
| 125 | Retinol metabolism_Homo sapiens_hsa00830 | 0.34089065 |
| 126 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.33524287 |
| 127 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.33137838 |
| 128 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.32192403 |
| 129 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31355357 |
| 130 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.31156190 |
| 131 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.29183727 |
| 132 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.29096671 |
| 133 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28244926 |
| 134 | Cell cycle_Homo sapiens_hsa04110 | 0.27749455 |
| 135 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.27481658 |
| 136 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.27201246 |
| 137 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26084834 |
| 138 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.26067118 |
| 139 | Melanogenesis_Homo sapiens_hsa04916 | 0.26014270 |
| 140 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.25749199 |
| 141 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.21650881 |
| 142 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.21607875 |
| 143 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20783864 |
| 144 | Mineral absorption_Homo sapiens_hsa04978 | 0.20412501 |
| 145 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.18829945 |
| 146 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.17727184 |
| 147 | Salmonella infection_Homo sapiens_hsa05132 | 0.16860346 |
| 148 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.16443554 |
| 149 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.15014382 |
| 150 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.12992306 |
| 151 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.12272311 |
| 152 | Lysosome_Homo sapiens_hsa04142 | 0.12153821 |
| 153 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.10658332 |
| 154 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.10381025 |

